Related Experiment Videos
Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids.
B W Van der Meer1, R D Fugate, P J Sims
1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City 73104.
Biophysical Journal
|November 1, 1989
Summary
The terminal complement proteins C5b-9 initiate phospholipid transbilayer exchange upon C8 binding. This process, involving approximately 1% of membrane phospholipids, is crucial for complement-mediated biological activities.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- The terminal complement pathway involves the assembly of the membrane attack complex (MAC), C5b-9.
- Understanding the interaction of complement proteins with cell membranes is crucial for elucidating their biological functions.
Purpose of the Study:
- To investigate transbilayer migration of membrane phospholipids induced by the terminal human complement proteins.
- To determine the specific complement protein complex responsible for initiating phospholipid movement.
Main Methods:
- Asymmetric vesicles with pyrene-labeled phosphatidylcholine (pyrenePC) in the inner monolayer were prepared.
- Vesicles were exposed to purified C5b-9 proteins, and transbilayer phospholipid exchange was monitored using pyrene excimer/monomer fluorescence.
- Complement protein C8 binding to the C5b67 complex was identified as the trigger for phospholipid migration.
Main Results:
- Membrane deposition of C5b67 complex did not alter pyrenePC fluorescence.
- Addition of C8 to C5b67-bound vesicles caused a dose-dependent decrease in the excimer/monomer ratio, indicating transbilayer phospholipid exchange.
- This effect was observed with or without C9, and not in control vesicles.
Conclusions:
- C8 binding to the C5b67 complex initiates transbilayer phospholipid exchange.
- Approximately 1% of total membrane phospholipid undergoes net transbilayer migration upon C8 binding.
- This phospholipid exchange may play a significant role in the biological activity of terminal complement proteins.